Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 575.00
Bid: 569.00
Ask: 572.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.527%)
Open: 573.00
High: 575.00
Low: 570.00
Prev. Close: 575.00
BAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

27 Sep 2022 07:00

RNS Number : 7115A
Barr(A.G.) PLC
27 September 2022
 

IMMEDIATE RELEASE 27 September 2022

A.G. BARR p.l.c.

("A.G. BARR" or "the Group")

A.G. BARR produces and markets some of the UK's leading drinks brands, including IRN-BRU, Rubicon and Funkin.

INTERIM RESULTS FOR THE 26 WEEKS ENDED 31 JULY 2022

Strong first half performance

Financial summary


26 wks to 31st July 2022

27 wks to 1 Aug 2021**

% Change

Revenue

£157.9m

£135.3m

16.7%

Reported profit before tax

£24.7m

£24.4m

1.2%

Adjusted profit before tax *

£25.3m

£20.6m

22.8%

Adjusted operating profit margin *

16.2%

16.2%

Flat

Cash and cash equivalents

£61.3m

£65.6m

(6.6%)

Basic EPS

18.98p

12.78p

48.5%

Interim dividend per share

2.50p

2.00p

25.0%

Highlights


Strong sales momentum across both business units : **

Barr Soft Drinks : Up 12.3%

Funkin : Up 21.4%

 

Trading benefited from year-on-year Covid-19 recovery, particularly in the on-trade and out of home sectors, as well as good summer weather

Core brand growth highlights our portfolio strength, our ability to flex price and promotions, the value we offer to consumers and customers, alongside the positive impact of brand innovation

Operating margin, while impacted by cost inflation, has been supported by sales growth, cost control and our pricing approach

Continued progress across "No Time To Waste" environmental sustainability programme including the approval of our near and long-term science-based emissions reduction targets with the Science Based Target initiative (SBTi). 

Strong balance sheet with £61.3m of cash and cash equivalents

Interim dividend of 2.5 pence per share representing an increase on the prior year of 25%

 

Roger White, Chief Executive, commented:

"We made a very strong start to the year and continue to see good momentum across our business and brands. That said, the UK's high level of inflation has accelerated across the summer and is creating a well documented cost of living crisis for many consumers, alongside increasing challenges for industry. 

We continue to take action to mitigate the cost pressures we face both in the short term across the balance of the current financial year and where possible into 2023. 

We anticipate in the coming months that the current economic environment will impact consumer purchasing behaviour, however we currently remain confident that our strategy and actions will allow us to deliver a full-year profit performance ahead of the prior year."

For more information, please contact :

A.G. BARR

0330 390 3900

 

Instinctif Partners

020 7457 2020

 

Roger White, Chief Executive

 

 

Justine Warren

 

Stuart Lorimer, Finance Director

 

Matthew Smallwood

 

_________________________________________________________________________________

 

Interim statement

We are pleased to report a strong performance in the first half of our 2022/23 financial year. 

Revenue was £157.9m representing year on year growth of :

● 20% on a like-for-like basis*, excluding both the 27th week in prior year** and the revenue contribution from MOMA Foods in the current reporting period

● 17% on a reported revenue basis (27 weeks** to 1 August 2021 : £135.3m) 

Reported profit before tax in the period was £24.7m (2021/22 H1 : £24.4m). This strong profit performance was supported by revenue growth across all of our core brands.

The prior year first half profit performance benefited from a number of one-off factors, as reported at the time, and therefore this year's strong H1 profit delivery is all the more positive.

Adjusted profit* in the period was £25.3m an increase of 22.8% on the prior year first half (2021/22 H1 : £20.6m). This takes into account the following :

● H1 2021/22 : the impact of the additional week and the gain on sale of property

● H1 2022/23 : the time value adjustment related to the MOMA deferred consideration

Inflation continued to accelerate across the UK in the reporting period. Against this backdrop we have actively managed our position through ongoing cost management actions and the successful execution of our pricing and promotional strategies across all our markets and channels.

 

Market context

Soft drinks : We maintained our value share of the total UK soft drinks market which increased by 8.1% across the period, while volume fell by 3.0%. Market performance was driven by broad-based consumer price inflation leading to significant value growth but reduced volumes. The soft drinks market also experienced year-on-year recovery in "drink now" out of home consumption in the more difficult to measure impulse channel. These dynamics are consistent across both carbonates and stills. 

(Source : IRI Marketplace data for the 26 weeks to 30 July 2022)

Cocktails : The value of GB cocktails across the ontrade continues to grow and is now worth £664m, up 13.2% year on year, while ready to drink (RTD) cocktails grew 24%, four times the rate of the RTD category as a whole.

(Source: Nielsen pre-mixed alcoholic drinks total coverage MAT 30/07/2022 ; CGA Q1 2022)

Oat milk : Across the UK grocery market, oat milk is growing 16% year on year, with one in three British consumers now drinking plant based milk. 

(Source: Kantar May 22, Nielsen 52 w/e July 2022, Mintel Sept 2021)

Business performance

Trading has been strong across both our business units with a 12.3% revenue increase across Barr Soft Drinks and Funkin's sales up 21.4%. 

The addition of the MOMA business has also supported our overall revenue performance. While, as anticipated, there is no positive impact on profit at this early stage, growth potential in this sector continues to be exciting. 

Growth across the Group has been driven by ongoing brand investment and the successful execution of our pricing and promotional activity. Trading performance further benefited from the year-on-year Covid-19 recovery across the market, particularly in the on-trade and out of home sectors, as well as good summer weather. The positive revenue growth in our core brands highlights the strength of our portfolio, our ability to flex price and promotions, the value we offer to consumers and customers as well as the positive impact of brand innovation - this includes further growth in Rubicon RAW Energy and Funkin nitro cocktails.

Operating margins in the period have been supported by sales growth, cost control and our pricing approach. We anticipate that this level of margin will not be sustained across the second half of the financial year given the impact of increasing costs, our continued brand investment and the volume impact of reduced consumer confidence. Therefore we anticipate our full year adjusted operating margin to be around 14%.

Cash flow and balance sheet

Net cash from operating activities was £11.4m, a decrease of £5.5m compared to 2021/22 (£16.9m). Cash generated from the growth in operating profit was offset by the impact of an increase in debtors associated with strong summer trading and increased inventory from a combination of inflation and higher stock cover.

Capital expenditure in the first half of the year was £7.0m (2021/22 H1 : £1.4m). This reflects investment in production capacity and capability, including new canning capacity at our Milton Keynes site and the commencement of our asset refresh programme at our Cumbernauld factory. Full year capital expenditure is estimated at £16-20m (2021/22 : £5m) and expected to be maintained at this level for at least two further years.

The Group closed the period with cash balances of £61.3m (2021/22 H1 : £65.6m), which was £7.4m less than the period opening position (£68.7m). Cash generated from operations funded the final 2021/22 dividend (£11.1m) paid in June, our capital investment programme and ongoing corporation tax payments (£3.4m).

Adjusted earnings per share* were 19.52p (2021/22: 9.36p). This significant increase on the prior period reflects the improved trading performance and the one-off impact in the prior period from the deferred tax adjustment arising from the change in corporation tax rate due in 2023. Excluding the one-off impact adjusted earnings per share grew by 35%.

Responsibility

We have continued to make good progress across our responsibility agenda, particularly with our "No Time To Waste" environmental sustainability programme. Highlights during the period include increased use of recycled material across our packaging as well as the approval of our near and long-term science-based emissions reduction targets with the Science Based Target initiative (SBTi) and an SBTi verified science-based net-zero target across our value chain of 2050. These targets are aligned with the SBTi's new Net-Zero Standard. ***

Dividend The Board has declared an interim dividend for the 26 weeks ended 31 July 2022 of 2.5 pence per share (2021/22 : 2.0 pence) payable on 28 October 2022 to shareholders on the register on 7 October 2022. 

Outlook

The UK's high level of inflation continued across the summer and is not expected to abate in the short-term, leading to challenging economic conditions for both consumers and industry.

We will continue to invest behind our brands to support long-term growth while at the same time taking appropriate mitigating action to limit the full year impact of cost inflation. 

Our brands are performing well and our business and people have continued to demonstrate both their resilience and flexibility. We anticipate in the coming months that the economic environment will impact consumer purchasing behaviour. However we currently remain confident that our portfolio of strong brands and our established strategy will allow us to deliver a full-year profit performance ahead of the prior year.

 

Mark Allen

Roger White

Chairman

Chief Executive

 

* Items marked with an asterisk are non-GAAP measures. Definitions and relevant reconciliations are provided at the end of this announcement

** 2021/22 was a 53-week financial year with a 27-week first half. 2022/23 reverts to a 52-week year with a 26-week first half

*** Full details of our science-based emissions reduction and science-based net-zero targets can be found at https://www.agbarr.co.uk/responsibility/no-time-to-waste/

 

 

Consolidated Condensed Income Statement

 

Unaudited

 

Unaudited

Audited

Six months ended 31 July 2022

 

Six months ended 1 August 2021

Year ended 30 January 2022

Total

 

Total

Total

Note

£m

 

£m

£m

Revenue

6

157.9

 

135.3

268.6

Cost of sales

(88.5)

 

(73.8)

(150.0)

Gross profit

6

69.4

 

61.5

118.6

Other income

-

 

0.7

0.7

Operating expenses

(43.9)

 

(37.6)

(76.6)

Operating profit

8

25.5

 

24.6

42.7

Finance costs

9

(0.7)

 

(0.2)

(0.4)

Share of results of associate

(0.1)

 

-

(0.1)

Profit before tax

24.7

 

24.4

42.2

Tax on profit

10

(3.8)

 

(10.2)

(14.4)

Profit for the period

20.9

 

14.2

27.8

Attributable to:

 

Equity shareholders of the parent Company

21.1

 

14.2

27.9

Non-controlling interests

(0.2)

 

-

(0.1)

Earnings per share (p)

 

Basic earnings per share

11

18.98

 

12.78

25.09

Diluted earnings per share

11

18.81

 

12.71

24.95

Consolidated Condensed Statement of Financial Position

 

Unaudited

Unaudited

Audited

As at 31 July 2022

As at 1 August 2021

As at 30 January 2022

Note

£m

£m

£m

Non-current assets

 

Intangible assets

97.9

89.8

98.6

Property, plant and equipment

96.6

93.3

93.8

Right-of-use assets

3.8

2.2

4.2

Loans and receivables

1.5

1.0

1.5

Investment in associates

0.6

0.8

0.7

200.4

187.1

198.8

Current assets

 

Inventories

24.0

17.8

24.2

Trade and other receivables

68.5

59.7

44.3

Derivative financial instruments

13

-

0.1

-

Current tax assets

0.6

-

0.3

Cash and cash equivalents

61.3

65.6

68.7

154.4

143.2

137.5

Total assets

 

354.8

330.3

336.3

Current liabilities

 

Loans and other borrowings

14

-

-

0.3

Trade and other payables

63.5

56.5

54.0

Derivative financial instruments

13

0.2

0.2

0.2

Lease liabilities

14

1.1

1.0

1.3

Provisions

0.9

1.4

2.0

Current tax liabilities

-

0.2

-

65.7

59.3

57.8

Non-current liabilities

 

Loans and other borrowings

14

0.2

-

-

Deferred tax liabilities

21.7

18.9

21.5

Lease liabilities

14

2.7

1.1

2.8

Put liabilities

5.6

-

5.0

Retirement benefit obligations

15

1.2

4.8

1.0

31.4

24.8

30.3

 

Capital and reserves attributable to equity holders

Share capital

4.7

4.7

4.7

Share premium account

0.9

0.9

0.9

Share options reserve

2.6

1.1

1.6

Other reserves

(5.1)

0.1

(5.1)

Retained earnings

251.1

239.4

242.4

Total shareholder equity

 

254.2

246.2

244.5

Non-controlling interest in equity

3.5

-

3.7

257.7

246.2

248.2

Total equity and liabilities

 

354.8

330.3

336.3

Consolidated Condensed Statement of Comprehensive Income

 

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

£m

£m

£m

Profit for the period

20.9

14.2

27.8

Other comprehensive income

 

Items that will not be reclassified to profit or loss

Remeasurements on defined benefit pension plans (Note 15)

(1.9)

1.5

4.7

Deferred tax movements on items above

0.5

(0.4)

(1.2)

Deferred tax remeasurement for movement in tax rate

-

1.5

1.5

Items that will be or have been reclassified to profit or loss

Cash flow hedges:

Gains arising during the period

-

(0.1)

0.1

Deferred tax movements on items above

-

-

-

Other comprehensive (expense)/income for the period, net of tax

(1.4)

2.5

5.1

Total comprehensive income for the period

19.5

16.7

32.9

Attributable to:

 

Equity shareholders of the parent Company

19.7

16.7

33.0

Non-controlling interests

(0.2)

-

(0.1)

 

Consolidated Condensed Statement of Changes in Equity (Unaudited)

 

Share capital

Share premium account

Share options reserve

Other reserves

Retained earnings

Total

Non-controlling interests

Total

 

£m

£m

£m

£m

£m

£m

£m

£m

 

At 30 January 2022

4.7

0.9

1.6

(5.1)

242.4

244.5

3.7

248.2

 

Profit for the period

-

-

-

-

21.1

21.1

(0.2)

20.9

Other comprehensive (expense)/income

-

-

-

-

(1.4)

(1.4)

-

(1.4)

Total comprehensive (expense)/income for the period

-

-

-

-

19.7

19.7

(0.2)

19.5

 

Recognition of share-based payment costs

-

-

1.0

-

-

1.0

-

1.0

Transfer of reserve on share award

-

-

(0.1)

-

0.1

-

-

-

Deferred tax on items taken directly to reserves

-

-

0.1

-

-

0.1

-

0.1

Dividends paid

-

-

-

-

(11.1)

(11.1)

-

(11.1)

At 31 July 2022

4.7

0.9

2.6

(5.1)

251.1

254.2

3.5

257.7

 

Consolidated Condensed Statement of Changes in Equity (Unaudited)

 

Share capital

Share premium account

Share options reserve

Other reserves

Retained earnings

Total

Non-controlling interests

Total

 

£m

£m

£m

£m

£m

£m

£m

£m

At 24 January 2021

4.7

0.9

1.8

(0.2)

221.6

228.8

-

228.8

Profit for the period

-

-

-

-

14.2

14.2

-

14.2

Other comprehensive (expense)/income

-

-

-

(0.1)

2.6

2.5

-

2.5

Total comprehensive (expense)/income for the period

-

-

-

(0.1)

16.8

16.7

-

16.7

Company shares purchased for use by employee benefit trusts (Note 16)

-

-

-

-

(0.1)

(0.1)

-

(0.1)

Recognition of share-based payment costs

-

-

0.4

-

-

0.4

-

0.4

Transfer of reserve on share award

-

-

(1.5)

-

1.5

-

-

-

Deferred tax on items taken directly to reserves

-

-

0.4

-

-

0.4

-

0.4

Reallocation between reserves

-

-

-

0.4

(0.4)

-

-

-

At 1 August 2021

4.7

0.9

1.1

0.1

239.4

246.2

-

246.2

Consolidated Condensed Statement of Changes in Equity (Audited)

 

Share capital

Share premium account

Share options reserve

Other reserves

Retained earnings

Total

Non-controlling interests

Total

£m

£m

£m

£m

£m

£m

£m

£m

At 24 January 2021

4.7

0.9

1.8

(0.2)

221.6

228.8

-

228.8

Profit for the year

-

-

-

-

27.9

27.9

(0.1)

27.8

Other comprehensive income

-

-

-

0.1

5.0

5.1

-

5.1

Total comprehensive income for the year

-

-

-

0.1

32.9

33.0

(0.1)

32.9

Company shares purchased for use by employee benefit trusts (Note 16)

-

-

-

-

(0.5)

(0.5)

-

(0.5)

Recognition of share-based payment costs

-

-

1.2

-

-

1.2

-

1.2

Transfer of reserve on share award

-

-

(1.8)

-

1.8

-

-

-

Recognition of non-controlling interests

-

-

-

(5.0)

-

(5.0)

3.8

(1.2)

Deferred tax on items taken direct to reserves

-

-

0.4

-

-

0.4

-

0.4

Dividends paid

-

-

-

-

(13.4)

(13.4)

-

(13.4)

At 30 January 2022

4.7

0.9

1.6

(5.1)

242.4

244.5

3.7

248.2

Consolidated Condensed Cash Flow Statement

 

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

£m

£m

£m

Operating activities

 

Profit for the period before tax

24.7

24.4

42.2

Adjustments for:

Finance costs

0.7

0.2

0.4

Depreciation of property, plant and equipment

4.9

5.2

9.9

Amortisation of intangible assets

0.7

0.7

1.3

Share-based payment costs

1.0

0.4

1.2

Gain on sale of fixed assets

(0.2)

(0.7)

(0.7)

Share of results of associates

0.1

-

0.1

Operating cash flows before movements in working capital

31.9

30.2

54.4

Decrease/(increase) in inventories

0.2

1.5

(4.3)

Increase in receivables

(24.2)

(22.1)

(5.6)

Increase in payables

8.6

12.4

7.7

Difference between employer pension contributions and amounts recognised in the income statement

(1.7)

(1.7)

(2.3)

Cash generated by operations

14.8

20.3

49.9

Tax paid

(3.4)

(3.4)

(6.5)

Net cash from operating activities

11.4

16.9

43.4

Investing activities

 

Acquisition of subsidiary (net of cash acquired)

-

-

(5.1)

Purchase of property, plant and equipment

(7.0)

(1.4)

(5.0)

Proceeds on sale of property, plant and equipment

0.2

1.1

1.1

Net cash used in investing activities

(6.8)

(0.3)

(9.0)

Financing activities

 

Loan receivable

-

-

(0.5)

Loans repaid

(0.1)

-

-

Lease payments

(0.8)

(0.8)

(1.5)

Purchase of Company shares by employee benefit trusts

-

(0.1)

(0.2)

Dividends paid

(11.1)

-

(13.4)

Interest paid

-

(0.1)

(0.1)

Net cash used in financing activities

(12.0)

(1.0)

(15.7)

Net increase in cash and cash equivalents

(7.4)

15.6

18.7

Cash and cash equivalents at beginning of period

68.7

50.0

50.0

Cash and cash equivalents at end of period

61.3

65.6

68.7

 

 

Notes to the Consolidated Condensed Financial Statements

 

1. General information

A.G. BARR p.l.c. (the "Company") and its subsidiaries (together the "Group") manufacture, market, distribute and sell soft drinks and cocktail solutions. The Group has manufacturing sites in the UK and sells mainly to customers in the UK with some international sales.

 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in Scotland. The address of its registered office is Westfield House, 4 Mollins Road, Cumbernauld, G68 9HD.

 

This consolidated condensed interim financial information does not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 January 2022 were approved by the Board of directors on 29 March 2022 and delivered to the Registrar of Companies. The comparative figures for the financial year ended 30 January 2022 are an extract of the Company's statutory accounts for that year. The report of the auditor on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under section 498 (2) or (3) of the Companies Act 2006.

 

This consolidated condensed interim financial information is unaudited but has been reviewed by the Company's Auditor.

 

2. Basis of preparation

This consolidated condensed interim financial information for the 26 weeks ended 31 July 2022 has been prepared in accordance with UK-adopted International Accounting Standard 34, 'Interim Financial Reporting' and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority. The interim report does not include all of the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the annual report for the year ended 30 January 2022, which has been prepared in accordance with UK-adopted international accounting standards and with the requirements of the Companies Act 2006.

 

Going concern basis

The directors have adopted the going concern basis in preparing these accounts after assessing the principal risks.

 

This assessment was undertaken through modelling a number of severe but plausible downside scenarios that could impact the business (both individually and cumulatively) over the period until January 2025. These scenarios include a global pandemic and associated restrictions, significant disruption to our supply chain, a cyber attack, significant energy cost inflation, and the impact of significant inflationary pressures on consumers. In each the Group continues to be cash generative throughout the forecast horizon, resulting in our liquidity headroom being maintained.

 

Our experience through the Covid-19 pandemic has given us confidence that the Group can remain profitable and cash-generative through prolonged disruption.

 

The most significant potential financial impact would be due to a significant reduction in sales. The revenue and operational leverage impact of such a volume loss would have a negative impact on Group profitability, however the scenario modelling would indicate that the Group would remain profitable over the next 12 months and we would anticipate a recovery in the following years.

 

The Group has £30m of committed and unutilised debt facilities, consisting of two revolving credit facilities from two individual banks, providing the business with a secure funding platform. One of these facilities (£10m) expires in April 2023, and will not be renewed given the Group's current liquidity headroom. The other facility (£20m) expires in February 2026. Throughout the above severe but plausible downside scenarios, the Group continues to have significant liquidity headroom on facilities and against revolving credit facilities financial covenants.

 

The directors believe that the Group is well placed to manage its financing and other business risks satisfactorily, and have a reasonable expectation that the Group and parent Company will have adequate resources to continue in operation for at least 12 months from the signing date of these condensed consolidated financial statements. They therefore consider it appropriate to adopt the going concern basis of accounting in preparing these financial statements.

 

3. Accounting policies

New standards and interpretations applied for the first time

There are no new or amended standards that became applicable for the current reporting period. The accounting policies set out in the annual financial statements for the year ended 30 January 2022 have been applied consistently to all periods presented in these Consolidated Condensed Interim Financial Statements.

 

New standards and interpretations not yet applied

There were no new or revised IFRS, amendments or interpretations in issue but not yet effective that are potentially material for the Group and which have not yet been applied.

 

4. Principal risks and uncertainties

The directors consider that the following principal risks and uncertainties could have a material impact on the Group's performance in the balance of the financial year. Further detail can be found on pages 52 - 56 of the Group's annual financial statements as at 30 January 2022, which are available on our website, www.agbarr.co.uk.

 

- Changes in consumer preferences, perception or purchasing behaviour

- Consumer rejection of enhanced sweeteners used in reformulated products

- Loss of product integrity

- Loss of continuity of supply of major raw materials

- Adverse publicity in relation to the soft drinks industry, the Group or its brands

- Government intervention on climate change and environmental issues e.g. packaging waste

- Failure to maintain customer relationships or take account of changing market dynamics

- Inability to protect the Group's intellectual property rights

- Failure of the Group's operational infrastructure

- Failure of critical IT systems or a breach of cyber security

- Financial risks

- Environmental Social and Governance (ESG) risks

- Cost inflation

 

The Group has reviewed its exposure to climate-related and other emerging business risks but has not identified any specific risks that would impact the financial performance or position of the Group at 31 July 2022.

 

5. Financial risk management and financial instruments

The Group's activities expose it to a variety of financial risks: market risk (including foreign exchange risk, cash flow and fair value interest rate risk and price risk), credit risk and liquidity risk.

 

The condensed interim financial statements should be read in conjunction with the Group's annual financial statements as at 30 January 2022 as they do not include all financial risk management information and disclosures contained within the annual financial statements. There have been no changes in the risk management policies since the year end.

 

6. Segment reporting

The Board and senior executives have been identified as the Group's chief operating decision-makers, who review the Group's internal reporting in order to assess performance and allocate resources.

 

The performance of the operating segments is assessed by reference to their gross profit.

 

During the year ended 30 January 2022, the Group amended the composition of reportable segments to better reflect internal reporting. Accordingly, the Group has restated the previously reported segment information for the 6 months ended 1 August 2021.

Unaudited

 

Six months ended 31 July 2022

 

Soft drinks

Cocktail solutions

Other

Total

 

£m

£m

£m

£m

 

Total revenue

131.0

22.7

4.2

157.9

 

Gross profit

58.9

9.1

1.4

69.4

 

 

Unaudited

 

Six months ended 1 August 2021 restated

 

Soft drinks

Cocktail solutions

Other

Total

£m

£m

£m

£m

Total revenue

116.6

18.7

-

135.3

Gross profit

54.2

7.3

-

61.5

Audited

 

Year ended 30 January 2022

 

Soft drinks

Cocktail solutions

Other

Total

£m

£m

£m

£m

Total revenue

230.6

36.9

1.1

268.6

Gross profit

103.5

14.7

0.4

118.6

There are no material intersegment sales. All revenue is in relation to product sales, which is recognised at point in time, upon delivery to the customer.

All of the assets and liabilities of the Group are managed on a central basis rather than at a segment level. As a result no reconciliations of segment assets and liabilities to the consolidated condensed statement of financial position has been disclosed for any of the periods presented.

Included in revenues arising from the above segments are revenues of approximately £30.5m which arose from sales to the Group's largest customer. In the year ended 30 January 2022 and six months ended 1 August 2021, revenues of approximately £51.5m and £28m respectively arose from sales to the Group's largest customer. No other single customers contributed 10 per cent or more to the Group's revenue in the comparative period to August 2021 or January 2022.

All of the segments included within "Soft drinks" and "Cocktail solutions" meet the aggregation criteria set out in IFRS 8 Operating Segments.

7. Seasonality of operations

 

Revenues and reported profits are affected by weather conditions, cost inflation, the timing of marketing and promotional investment and innovation launches. It is anticipated that the reported profits for the second half of the year to 29 January 2023 will be lower than those for the 26 weeks ended 31 July 2022.

8. Operating profit

 

The following items have been charged/(credited) to operating profit during the period:

 

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

£m

£m

£m

Gain on sale of property, plant and equipment

(0.2)

(0.7)

(0.7)

Impairment of inventories

0.1

0.1

0.2

Foreign exchange gains recognised

(0.1)

(0.2)

(0.2)

Inventories are stated at the lower of cost and net realisable value. Net realisable value is the estimated selling price in the ordinary course of business less the estimated costs of completing production and selling expenses.

 

9. Finance costs

 

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

£m

£m

£m

Interest payable

(0.1)

(0.1)

(0.2)

Lease interest

-

-

(0.1)

Finance costs relating to defined benefit pension plans

-

(0.1)

(0.1)

Unwind of put option discount

(0.6)

-

-

 

(0.7)

(0.2)

(0.4)

 

10. Tax on profit

The interim period total tax charge of £3.8m (six months ended 1 August 2021: £10.2m; year ended 30 January 2022: £14.4m) is accrued based on the estimated annual effective tax rate of 15.4% (six months ended 1 August 2021: 41.8%; year ended 30 January 2022: 34.1%). The effective tax rate in the current year has decreased as a result of the remeasurement of deferred tax balances in the prior year and the increase in capital allowances available. In March 2021, the UK government announced that the corporation tax rate would increase from 19% to 25% effective from 1 April 2023 which was substantively enacted on 24 May 2021. The impact of this was a one-off increase in the deferred tax charge of £5.7m in the comparative reporting periods. Excluding the impact of the change in tax rate the effective tax rate for the six months ended 1 August 2021 was 17.6%. The Finance Act 2022, which received Royal Assent on 24 February 2022, will not have any impact on the corporation tax figures. However, in the September 2022 Mini Budget it was announced that the increase to 25% would now not occur and the Corporation Tax Rate would instead be held at 19%. This rate had not been substantively enacted at the balance sheet date, and as a result the deferred tax balances as at 31 July 2022 were measured using the 25% noted above. The estimated impact of the reversal of the corporation tax rate increase would be to reduce the deferred tax liability by around £5m.

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

Analysis of tax charge

£m

£m

£m

Current income tax charge

3.2

4.4

6.8

Deferred income tax charge

0.6

5.8

7.6

Total tax charge in the condensed income statement

3.8

10.2

14.4

 

 

11. Earnings per share

 

Basic earnings per share has been calculated by dividing the earnings attributable to equity holders of the parent by the weighted average number of shares in issue during the year, excluding shares held by the employee share scheme trusts.

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

Profit attributable to equity holders of the Company (£m)

21.1

14.2

27.9

Weighted average number of ordinary shares in issue

111,192,917

111,104,168

111,187,778

Basic earnings per share (pence)

18.98

12.78

25.09

For diluted earnings per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all potentially dilutive ordinary shares. These represent share options granted to employees where the exercise price is less than the average market price of the Company's ordinary shares during the period. The number of shares calculated as above is compared with the number of shares that would have been issued assuming the exercise of the share options.

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

Profit attributable to equity holders of the Company (£m)

21.1

14.2

27.9

Weighted average number of ordinary shares in issue

111,192,917

111,104,168

111,187,778

Adjustment for dilutive effect of share options

998,620

633,701

657,074

Diluted weighted average number of ordinary shares in issue

112,191,537

111,737,869

111,844,852

Diluted earnings per share (pence)

18.81

12.71

24.95

12. Dividends

 

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

per share (p)

per share (p)

per share (p)

£m

£m

£m

Paid final dividend

10.00

-

-

11.1

-

-

Paid interim dividend

-

-

2.00

-

-

2.2

Paid special dividend

-

-

10.00

-

-

11.2

10.00

-

12.00

11.1

-

13.4

An interim dividend of 2.5 pence per share was approved by the Board on 27 September 2022 and will be paid on 28th October 2022 to shareholders on the register as at 7th October 2022.

 

13. Financial instruments

Current assets of £nil (at 1 August 2021: £0.1m; 30 January 2022: £nil) relate to forward foreign currency contracts with a maturity of less than 12 months and are recognised at fair value through the cash flow hedge reserve, included within other reserves.

Current liabilities of £0.2m (at 1 August 2021: £0.2m; 30 January 2022: £0.2m) relate to forward foreign currency contracts with a maturity of less than 12 months and are recognised at fair value through the cash flow hedge reserve, included within other reserves.

Fair value hierarchy

Fair value hierarchies 1 to 3 are based on the degree to which fair value is observable:

Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities

Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices)

Level 3: inputs for the asset or liability that are not based on observable market data

The fair value of financial instruments that are not traded in an active market (for example, over-the-counter derivatives) is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. The fair value of the forward foreign exchange contracts is determined using forward exchange rates at the date of the consolidated condensed statement of financial position, with the resulting value discounted accordingly as relevant.

All financial instruments carried at fair value are Level 2.

Fair values of financial assets and financial liabilities

The following table shows the carrying amounts and fair values of financial assets and financial liabilities. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.

Carrying amount

Unaudited

 

Fair value - hedging instruments

Other financial assets at amortised cost

Other financial liabilities at amortised cost

Total

As at 31 July 2022

 

£m

£m

£m

£m

Financial assets - Non-current

Loan receivable

-

0.5

-

0.5

Loan receivable from associate

-

1.0

-

1.0

 

-

1.5

-

1.5

Financial assets - Current

Trade receivables

-

68.5

-

68.5

Cash and cash equivalents

-

61.3

-

61.3

 

-

129.8

-

129.8

Financial liabilities - Non-current

Bank borrowings

-

-

0.2

0.2

Lease liabilities

-

-

2.7

2.7

-

-

2.9

2.9

Financial liabilities - Current

Foreign exchange contracts used for hedging

0.2

-

-

0.2

Lease liabilities

-

-

1.1

1.1

Trade payables

-

-

63.5

63.5

 

0.2

-

64.6

64.8

 

Carrying amount

Unaudited

Fair value - hedging instruments

Other financial assets at amortised cost

Other financial liabilities at amortised cost

Total

As at 1 August 2021

£m

£m

£m

£m

Financial assets - Non-current

Loan receivable from associate

-

1.0

-

1.0

-

1.0

-

1.0

Financial assets - Current

Foreign exchange contracts used for hedging

0.1

-

-

0.1

Trade receivables

-

56.9

-

56.9

Cash and cash equivalents

-

65.6

-

65.6

0.1

122.5

-

122.6

Financial liabilities - Non-current

Lease liabilities

-

-

1.1

1.1

-

-

1.1

1.1

Financial liabilities - Current

Foreign exchange contracts used for hedging

0.2

-

-

0.2

Lease liabilities

-

-

1.0

1.0

Trade payables

-

-

13.3

13.3

0.2

-

14.3

14.5

Carrying amount

Audited

Fair value - hedging instruments

Other financial assets at amortised cost

Other financial liabilities at amortised cost

Total

As at 30 January 2022

£m

£m

£m

£m

Financial assets - Non-current

Loan receivable

-

0.5

-

0.5

Loan receivable from associate

-

1.0

-

1.0

-

1.5

-

1.5

Financial assets - Current

Trade receivables

-

41.6

-

41.6

Cash and cash equivalents

-

68.7

-

68.7

-

110.3

-

110.3

Financial liabilities - Non-current

Lease liabilities

-

-

2.8

2.8

-

-

2.8

2.8

Financial liabilities

Bank borrowings

-

-

0.3

0.3

Foreign exchange contracts used for hedging

0.2

-

-

0.2

Lease liabilities

-

-

1.3

1.3

Trade payables

-

-

15.8

15.8

0.2

-

17.4

17.6

 

14. Loans and other borrowings

 

Movements in borrowings are analysed as follows:

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

£m

£m

£m

Opening borrowings balance

4.4

5.4

5.4

Net lease payments

(0.3)

(0.4)

(1.3)

Borrowings acquired

-

-

0.3

Bank overdraft/loans repaid

(0.1)

(2.9)

-

Closing borrowings balance

4.0

2.1

4.4

The reconciliation of the above closing borrowings balance to the figures on the face of the consolidated condensed statement of financial position is as follows:

Unaudited

Unaudited

Audited

As at 31 July 2022

As at 2 August 2021

As at 30 January 2022

£m

£m

£m

Bank borrowings

0.2

-

0.3

Lease liabilities

3.8

2.1

4.1

Total borrowings and loans

4.0

2.1

4.4

Disclosed as

Current liabilities

1.1

1.0

1.6

Non-current liabilities

2.9

1.1

2.8

The reconciliation to net debt is as follows:

Unaudited

Unaudited

Audited

As at 31 July 2022

As at 1 August 2021

As at 30 January 2022

£m

£m

£m

Closing borrowings balance

(4.0)

(2.1)

(4.4)

Cash and cash equivalents

61.3

65.6

68.7

Net funds

57.3

63.5

64.3

The drawn/undrawn facilities at 31 July 2022 are as follows:

Total facility

Drawn

Undrawn

£m

£m

£m

Revolving credit facility - three years, expires April 2023

10.0

-

10.0

Revolving credit facility - five years, expires February 2026

20.0

-

20.0

Overdraft

5.1

-

5.1

CBILS loan facility - six years, expires June 2026

0.2

0.2

-

 

35.3

0.2

35.1

 

 

15. Retirement benefit obligations

On 1 May 2016 the A.G. BARR p.l.c. (2008) Pension and Life Assurance Scheme was closed to future accrual following a negotiated agreement between the Company and the board of trustees.

The defined retirement benefit scheme had a deficit of £1.2m as at 31 July 2022 (as at 1 August 2021: £4.8m, 30 January 2022: £1.0m). The reconciliation of the closing deficit is as follows:

Unaudited

Unaudited

Audited

Six months ended 31 July 2022

Six months ended 1 August 2021

Year ended 30 January 2022

£m

£m

£m

Opening present value of obligation

(114.9)

(123.9)

(123.9)

Current service cost

-

-

(0.1)

Interest cost

(1.2)

(0.9)

(1.7)

Remeasurement - changes in financial assumptions

20.6

(1.4)

6.4

Benefits paid

2.5

2.8

4.4

Closing position

(93.0)

(123.4)

(114.9)

Opening fair value of plan assets

113.9

116.0

116.0

Interest income

1.2

0.8

1.6

Remeasurement - actuarial return on assets

(22.5)

2.9

(1.7)

Employer contributions

1.7

1.7

2.4

Benefits paid

(2.5)

(2.8)

(4.4)

Closing fair value of plan assets

91.8

118.6

113.9

As at 31 July 2022

As at 1 August 2021

As at 30 January 2022

£m

£m

£m

Closing present value of obligation

(93.0)

(123.4)

(114.9)

Closing fair value of plan assets

91.8

118.6

113.9

Closing net deficit

(1.2)

(4.8)

(1.0)

The key financial assumptions used to value the liabilities were as follows:

As at 31 July 2022

As at 1 August 2021

As at 30 January 2022

%

%

%

Discount rate

3.5

1.6

2.2

Inflation assumption

3.2

3.3

3.6

 

16. Movements in own shares held by employee benefit trusts

During the six months to 31 July 2022 the employee benefit trusts of the Group acquired 20,613 (six months to 1 August 2021: 21,936; year to 30 January 2022: 42,778) of the Company's shares. The total amount paid to acquire the shares has been deducted from shareholders' equity and is included within retained earnings. At 31 July 2022 the shares held by the Company's employee benefit trusts represented 787,283 (1 August 2021: 781,002; 30 January 2022: 679,758) shares at a purchased cost of £4.7m (1 August 2021: £4.7m; 30 January 2022: £4.7m).

 

16,203 (six months to 1 August 2021: 112,594; year to 30 January 2022: 131,565) shares were utilised in satisfying share options from the Company's employee share schemes during the same period. The related weighted average share price at the time of exercise for the six months to 31 July 2022 was £5.30 (six months to 1 August 2021: £5.19; year to 30 January 2022: £5.19)

 

17. Contingencies and commitments

Unaudited

Unaudited

Audited

As at 31 July 2022

As at 1 August 2021

As at 30 January 2022

£m

£m

£m

Commitments for the acquisition of property, plant and equipment

21.9

0.6

9.5

18. Related party transactions

There have been no related party transactions in the first 26 weeks of the current financial year which have materially affected the financial position or performance of the Group.

 

RESPONSIBILITY AND CAUTIONARY STATEMENTS

 

RESPONSIBILITY STATEMENT

Company law requires the directors to prepare statements for each financial year. Under that law the directors are required to prepare group financial statements in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and UK-adopted International Financial Reporting Standards.

 

The directors confirm that these consolidated condensed interim financial statements have been prepared in accordance with International Accounting Standard 34 Interim Financial Reporting. The interim management report includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

 

• an indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

• material related party transactions in the first six months and any material changes in the related party transactions described in the last annual report.

 

CAUTIONARY STATEMENT

This report is addressed to the shareholders of A.G. BARR p.l.c. and has been prepared solely to provide information to them.

 

This report is intended to inform the shareholders of the Group's performance during the six months to 31 July 2022. This report contains forward-looking statements based on knowledge and information available to the directors as at the date the report was prepared. These statements should be treated with caution due to the inherent uncertainties underlying any such forward-looking information and any statements about the future outlook may be influenced by factors that could cause actual outcomes and results to be materially different.

 

The directors of A.G. BARR p.l.c. that served during the six months to 31 July 2022 and up to the date of signing, and their respective responsibilities, were:

 

M. Allen OBE (Chairman)

J.R. Nicolson (resigned 31 March 2022)

R.A. White (Chief Executive)

S. Lorimer (Finance Director)

J.D. Kemp (Commercial Director)

W.R.G Barr

S.V. Barratt

Z.L. Howorth

D.J. Ritchie

N.B.E. Wharton

 

 

For and on behalf of the Board of directors

 

 

 

Roger White

Chief Executive

27 September 2022

Stuart Lorimer

Finance Director

27 September 2022

 

Glossary

 

Non-GAAP measures are provided because they are tracked by management to assess the Group's operating performance and to inform financial, strategic and operating decisions.

 

Adjusting items

The Group excludes adjusting items from its non-GAAP measures because of their size, frequency and nature to allow shareholders to understand better the elements of financial performance in the year, so as to facilitate comparison with prior periods and to assess trends in financial performance more readily. These items are primarily non-operational.

 

Definitions of non-GAAP measures used are provided below:

 

Capital expenditure is a non-GAAP measure and is defined as the cash purchases of property, plant and equipment and is disclosed in the consolidated condensed cash flow statement.

 

Adjusted profit attributable to equity holders is a non-GAAP measure calculated as adjusted profit attributable to equity holders.

 

Adjusted earnings per share is a non-GAAP measure calculated by dividing adjusted profit attributable to equity holders by the weighted average number of shares in issue.

 

Adjusted operating margin is a non-GAAP measure calculated by dividing adjusted operating profit by revenue.

 

Adjusted profit attributable to equity holders is a non-GAAP measure calculated as adjusted profit attributable to equity holders.

 

Adjusted profit before tax is a non-GAAP measure calculated as reported profit before tax after adjusting items.

 

Like for like revenue growth is a non-GAAP measure comparing adjusted revenue less MOMA revenue to the prior period adjusted revenue.

Reconciliation of Non-GAAP measures

Adjusted Consolidated Income Statements

 

Six months ended 31 July 2022

 

Six months ended 1 August 2021

Year ended 30 January 2022

Reported

 

Unwind of discount

 

Adjusted

 

Reported

Gain on sale of property

Extra week trading

Adjusted

Reported

Gain on sale of property

Extra week trading

Adjusted

£m

 

£m

 

£m

 

£m

£m

£m

£m

£m

£m

£m

Revenue

157.9

 

-

157.9

 

135.3

-

(6.8)

128.5

268.6

-

(6.8)

261.8

Cost of sales

(88.5)

 

-

(88.5)

 

(73.8)

-

3.7

(70.1)

(150.0)

-

3.7

(146.3)

Gross profit

69.4

 

-

 

69.4

 

61.5

-

(3.1)

58.4

118.6

-

(3.1)

115.5

Other income

-

 

-

 

-

 

0.7

(0.7)

-

-

0.7

(0.7)

-

-

Operating expenses

(43.9)

 

(43.9)

 

(37.6)

-

-

(37.6)

(76.6)

-

-

(76.6)

Operating profit

25.5

 

-

 

25.5

 

24.6

(0.7)

(3.1)

20.8

42.7

(0.7)

(3.1)

38.9

Share of results of associate

(0.1)

 

-

 

(0.1)

 

-

-

-

-

(0.1)

-

-

(0.1)

Finance costs

(0.7)

 

0.6

 

(0.1)

 

(0.2)

-

-

(0.2)

(0.4)

-

-

(0.4)

Profit before tax

24.7

 

0.6

 

25.3

 

24.4

(0.7)

(3.1)

20.6

42.2

(0.7)

(3.1)

38.4

Tax on profit

(3.8)

 

-

(3.8)

 

(10.2)

-

-

(10.2)

(14.4)

-

-

(14.4)

Profit for the period

20.9

 

0.6

 

21.5

 

14.2

(0.7)

(3.1)

10.4

27.8

(0.7)

(3.1)

24.0

Attributable to:

 

Equity shareholders of the parent Company

21.1

 

0.6

 

21.7

 

14.2

-

10.4

27.9

-

24.1

Non-controlling interests

(0.2)

 

-

 

(0.2)

 

-

-

-

(0.1)

-

(0.1)

Adjusting entries:

Unwind of discount - the time value adjustment of the put liability held on balance sheet.

Gain on sale of property - the gain on the disposal of the Sheffield distribution depot.

Extra week trading - the 6 months to 1 August 2021 was a 27 week period and the year ended 30 January 2022 was a 53 week period. This extra week of trading is removed for comparative purposes.

 

Adjusted EPS

 

Adjusted profit attributable to equity holders of the Company £m

21.7

 

10.4

24.1

Weighted average number of shares in issue

111,192,917

 

111,104,168

111,187,778

Adjusted EPS (p)

19.52

 

9.36

21.68

Adjusted operating margin

£m

 

£m

£m

Revenue

157.9

 

128.5

261.8

Adjusted operating profit

25.5

 

20.8

38.9

Adjusted operating margin

16.2%

 

16.2%

14.9%

Like for like revenue growth

£m

 

Adjusted revenue for period to 31 July 2022

157.9

 

Less MOMA revenue

(4.2)

 

153.7

 

Adjusted revenue for period to 1 August 2021

128.5

 

Movement

25.2

 

Growth

20%

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EAPNKADKAEFA
Date   Source Headline
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.